Immutep (IMMP) Net Shares Issued and Repurchased (2011 - 2025)
Immutep's (IMMP) quarterly Net Shares Issued and Repurchased came in at $359.6 million in Q4 2025, up 1.25% YoY from $355.1 million in Q4 2024, and up 3.07% on a QoQ basis from $348.9 million in Q2 2025.
Immutep (IMMP) Net Shares Issued and Repurchased (2011 - 2025) Analysis & Trends
Immutep (IMMP) has 15 years of Net Shares Issued and Repurchased data on file, last reported at $359.6 million in Q4 2025.
- Quarterly Net Shares Issued and Repurchased rose 1.25% year-over-year to $359.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $359.6 million (up 1.25% YoY) and the FY2025 annual result came in at $348.9 million, down 2.35% from the prior year.
- Net Shares Issued and Repurchased advanced to $359.6 million in Q4 2025, from $348.9 million in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $359.6 million in Q4 2025 to a low of $241.4 million in Q2 2021.
- A 5-year average of $302.4 million and a median of $294.5 million in 2023 frame the typical range for Net Shares Issued and Repurchased.
- Annual changes were most pronounced in 2021 — Net Shares Issued and Repurchased soared 51.55% — and 2022, when it dropped 8.58%.
- Tracing IMMP's Net Shares Issued and Repurchased over 5 years: stood at $266.2 million in 2021, then fell by 8.58% to $243.3 million in 2022, then advanced by 19.52% to $290.8 million in 2023, then rose by 22.12% to $355.1 million in 2024, then gained by 1.25% to $359.6 million in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $359.6 million (Q4 2025), $348.9 million (Q2 2025), and $355.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | 359.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 359.58 Mn |
| Dec 31, 2025 | 359.58 Mn |
| Jun 30, 2025 | 348.86 Mn |
| Jun 30, 2025 | 348.86 Mn |
| Dec 31, 2024 | 355.14 Mn |
| Dec 31, 2024 | 355.14 Mn |
| Jun 30, 2024 | 357.26 Mn |
| Jun 30, 2024 | 357.26 Mn |
| Dec 31, 2023 | 290.80 Mn |
| Dec 31, 2023 | 290.80 Mn |
| Jun 30, 2023 | 298.27 Mn |
| Jun 30, 2023 | 298.27 Mn |
| Dec 31, 2022 | 243.32 Mn |
| Dec 31, 2022 | 243.32 Mn |
| Jun 30, 2022 | 263.16 Mn |
| Jun 30, 2022 | 263.16 Mn |
| Dec 31, 2021 | 266.16 Mn |
| Dec 31, 2021 | 266.16 Mn |
| Jun 30, 2021 | 241.35 Mn |
| Jun 30, 2021 | 241.35 Mn |